Downregulation of tryptophan-related metabolomic profile in rheumatoid arthritis synovial fluid

Journal of Rheumatology

Volumn 42, Issue 11, 2015, Pages 2003-2011

  Kang, Kwi Young ^a   Lee, Soo Hyun ^a   Jung, Seung Min ^b   Park, Sung Hwan ^b   Jung, Byung Hwa ^c   Ju, Ji Hyeon ^d  

^a Kongju National University   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c University of Science and Technology (UST)   (South Korea)

^d The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Mass spectrometry; Metabolomics; Rheumatoid arthritis; Synovial fluid osteoarthritis; Tryptophan

Indexed keywords

ARACHIDONIC ACID; C REACTIVE PROTEIN; CARNITINE; CHOLESTEROL ESTER; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; GLYCOPHOSPHOLIPID; INDOLE ACETALDEHYDE; INDOLEACETIC ACID; KYNURENINE; LINOLENIC ACID; MARKER; N' FORMYLKYNURENINE; PHENYLALANINE; PRISTANIC ACID; RHEUMATOID FACTOR; SPHINGOLIPID; TAURINE; TRYPTOPHAN; UNCLASSIFIED DRUG; AUTOANTIBODY; BIOLOGICAL MARKER;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ERYTHROCYTE SEDIMENTATION RATE; FATTY ACID OXIDATION; FEMALE; HUMAN; METABOLOMICS; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; TIME OF FLIGHT MASS SPECTROMETRY; TRYPTOPHAN METABOLISM; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; AGED; BLOOD; COMPARATIVE STUDY; DISEASE COURSE; EPIDEMIOLOGY; FOLLOW UP; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PROCEDURES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOMARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CHROMATOGRAPHY, LIQUID; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSTEOARTHRITIS; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SYNOVIAL FLUID; TRYPTOPHAN;

EID: 84946575534     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.141505     Document Type: Article

References (34)

1. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet 2010;376:1094-108.
2. Andersson AK, Li C, Brennan FM. Recent developments in the immunobiology of rheumatoid arthritis. Arthritis Res Ther 2008;10:204.
3. Huber LC, Distler O, Tarner I, Gay RE, Gay S, Pap T. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology 2006;45:669-75.
4. Attur M, Krasnokutsky-Samuels S, Samuels J, Abramson SB. Prognostic biomarkers in osteoarthritis. Curr Opin Rheumatol 2013;25:136-44.
5. Ruiz-Romero C, Blanco FJ. Proteomics role in the search for improved diagnosis, prognosis and treatment of osteoarthritis. Osteoarthritis Cartilage 2010;18:500-9.
6. Hui AY, McCarty WJ, Masuda K, Firestein GS, Sah RL. A systems biology approach to synovial joint lubrication in health, injury, and disease. Wiley Interdiscip Rev Syst Biol Med 2012;4:15-37.
7. Priori R, Scrivo R, Brandt J, Valerio M, Casadei L, Valesini G, et al. Metabolomics in rheumatic diseases: the potential of an emerging methodology for improved patient diagnosis, prognosis, and treatment efficacy. Autoimmun Rev 2013;12:1022-30.
8. Johnson CH, Gonzalez FJ. Challenges and opportunities of metabolomics. J Cell Physiol 2012;227:2975-81.
9. Young SP, Kapoor SR, Viant MR, Byrne JJ, Filer A, Buckley CD, et al. The impact of inflammation on metabolomic profiles in patients with arthritis. Arthritis Rheum 2013;65:2015-23.
10. Balakrishnan L, Bhattacharjee M, Ahmad S, Nirujogi RS, Renuse S, Subbannayya Y, et al. Differential proteomic analysis of synovial fluid from rheumatoid arthritis and osteoarthritis patients. Clin Proteomics 2014;11:1.
11. Uchida T, Fukawa A, Uchida M, Fujita K, Saito K. Application of a novel protein biochip technology for detection and identification of rheumatoid arthritis biomarkers in synovial fluid. J Proteome Res 2002;1:495-9.
12. Mateos J, Lourido L, Fernández-Puente P, Calamia V, Fernández-López C, Oreiro N, et al. Differential protein profiling of synovial fluid from rheumatoid arthritis and osteoarthritis patients using LC-MALDI TOF/TOF. J Proteomics 2012;75:2869-78.
13. Hügle T, Kovacs H, Heijnen IA, Daikeler T, Baisch U, Hicks JM, et al. Synovial fluid metabolomics in different forms of arthritis assessed by nuclear magnetic resonance spectroscopy. Clin Exp Rheumatol 2012;30:240-5.
14. Slupsky CM, Rankin KN, Wagner J, Fu H, Chang D, Weljie AM, et al. Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal Chem 2007; 79:6995-7004.
15. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
16. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957;16:494-502.
17. Sangster T, Major H, Plumb R, Wilson AJ, Wilson ID. A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis. Analyst 2006;131:1075-8.
18. Gika HG, Theodoridis GA, Wilson ID. Liquid chromatography and ultra-performance liquid chromatography-mass spectrometry fingerprinting of human urine: sample stability under different handling and storage conditions for metabonomics studies. J Chromatogr A 2008;1189:314-22.
19. Gika HG, Theodoridis GA, Wingate JE, Wilson ID. Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine. J Proteome Res 2007; 6:3291-303.
20. Lai L, Michopoulos F, Gika H, Theodoridis G, Wilkinson RW, Odedra R, et al. Methodological considerations in the development of HPLC-MS methods for the analysis of rodent plasma for metabonomic studies. Mol Biosyst 2010;6:108-20.
21. Plumb RS, Johnson KA, Rainville P, Smith BW, Wilson ID, Castro-Perez JM, et al. UPLC/MS(E); a new approach for generating molecular fragment information for biomarker structure elucidation. Rapid Commun Mass Spectrom 2006;20:1989-94.
22. Xing J, Chen X, Sun Y, Luan Y, Zhong D. Interaction of baicalin and baicalein with antibiotics in the gastrointestinal tract. J Pharm Pharmacol 2005;57:743-50.
23. Bylesjö M, Eriksson D, Sjödin A, Jansson S, Moritz T, Trygg J. Orthogonal projections to latent structures as a strategy for microarray data normalization. BMC Bioinformatics 2007;8:207.
24. Fitzpatrick M, Young SP. Metabolomics - a novel window into inflammatory disease. Swiss Med Wkly 2013;143:w13743.
25. Chen M, Lam BK, Kanaoka Y, Nigrovic PA, Audoly LP, Austen KF, et al. Neutrophil-derived leukotriene B4 is required for inflammatory arthritis. J Exp Med 2006;203:837-42.
26. Oliviero F, Lo Nigro A, Bernardi D, Giunco S, Baldo G, Scanu A, et al. A comparative study of serum and synovial fluid lipoprotein levels in patients with various arthritides. Clin Chim Acta 2012;413:303-7.
27. Schwarz IM, Hills BA. Synovial surfactant: lamellar bodies in type B synoviocytes and proteolipid in synovial fluid and the articular lining. Br J Rheumatol 1996;35:821-7.
28. Kosinska MK, Liebisch G, Lochnit G, Wilhelm J, Klein H, Kaesser U, et al. A lipidomic study of phospholipid classes and species in human synovial fluid. Arthritis Rheum 2013;65:2323-33.
29. Fuchs B, Schiller J, Wagner U, Häntzschel H, Arnold K. The phosphatidylcholine/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: investigations by 31P NMR and MALDI-TOF MS. Clin Biochem 2005;38:925-33.
30. Masferrer JL, Seibert K. Regulation of prostaglandin synthesis by glucocorticoids. Receptor 1994;4:25-30.
31. Fallarino F, Grohmann U, Vacca C, Bianchi R, Orabona C, Spreca A, et al. T cell apoptosis by tryptophan catabolism. Cell Death Differ 2002;9:1069-77.
32. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 1999;189:1363-72.
33. Williams RO. Exploitation of the IDO pathway in the therapy of rheumatoid arthritis. Int J Tryptophan Res 2013;6 Suppl 1:67-73.
34. Nguyen NT, Kimura A, Nakahama T, Chinen I, Masuda K, Nohara K, et al. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc Natl Acad Sci U S A 2010;107:19961-6.